Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment

Critical Care

Volumn 18, Issue 5, 2014, Pages

  Behnes, Michael ^a   Bertsch, Thomas ^b   Lepiorz, Dominic ^a   Lang, Siegfried ^a   Trinkmann, Frederik ^a   Brueckmann, Martina ^c   Borggrefe, Martin ^a   Hoffmann, Ursula ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Paracelsus Medical University   (Germany)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CATECHOLAMINE; CD14 ANTIGEN; INTERLEUKIN 6; PRESEPSIN; PROCALCITONIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CALCITONIN; PEPTIDE FRAGMENT; PRESEPSIN PROTEIN, HUMAN; PROTEIN PRECURSOR;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INTENSIVE CARE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RENAL REPLACEMENT THERAPY; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; SURVIVAL TIME; BLOOD; CLASSIFICATION; CLINICAL TRIAL; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; MIDDLE AGED; SHOCK, SEPTIC; TIME FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; BIOMARKERS; C-REACTIVE PROTEIN; CALCITONIN; CRITICAL CARE; FEMALE; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; ROC CURVE; SEPSIS; SHOCK, SEPTIC; TIME FACTORS;

EID: 84908086516     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-014-0507-z     Document Type: Article

References (28)

1. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41:580-637. 10.1097/CCM.0b013e31827e83af, 23353941.
2. Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. Lancet 2010, 376:1339-1346. 10.1016/S0140-6736(10)60446-1, 20934212.
3. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013, 369:840-851. 10.1056/NEJMra1208623, 23984731.
4. Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother 2011, 66:ii33-ii40. 10.1093/jac/dkq523, 21398306.
5. Sridharan P, Chamberlain RS. The Efficacy of Procalcitonin as a Biomarker in the Management of Sepsis: Slaying Dragons or Tilting at Windmills?. Surg Infect (Larchmt) 2013, 14:489-511. 10.1089/sur.2012.028.
6. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013, 13:426-435. 10.1016/S1473-3099(12)70323-7, 23375419.
7. Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother 2011, 17:764-769. 10.1007/s10156-011-0254-x, 21560033.
8. Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta 2011, 412:157-161. 10.1016/j.cca.2011.07.024.
9. Shirakawa K, Naitou K, Hirose J, Takahashi T, Furusako S. Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients. Clin Chem Lab Med 2011, 49:937-939. 10.1515/CCLM.2011.145, 21345045.
10. Sugie Y, Igami K, Shoji K, Arai N, Tazaki Y, Kouta H, Okamura Y, Tashiro S, Yokoi H. Performance evaluation of the new rapid fertility assays in whole blood and plasma on PATHFAST. Clin Lab 2011, 57:99-106. 21391473.
11. Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, Nishida T, Irie Y, Miura M, Iguchi H, Fukui Y, Tanaka K, Nojima T, Okamura Y. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother 2012, 18:891-897. 10.1007/s10156-012-0435-2, 22692596.
12. Chenevier-Gobeaux C, Trabattoni E, Roelens M, Borderie D, Claessens YE. Presepsin (sCD14-ST) in emergency department: The need for adapted threshold values?. Clin Chim Acta 2013, 427C:34-36.
13. Liu B, Chen YX, Yin Q, Zhao YZ, Li CS. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department. Crit Care 2013, 17:R244. 10.1186/cc13070, 24138799.
14. Ulla M, Pizzolato E, Lucchiari M, Loiacono M, Soardo F, Forno D, Morello F, Lupia E, Moiraghi C, Mengozzi G, Battista S. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Crit Care 2013, 17:R168. 10.1186/cc12847, 23899120.
15. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.Crit Care Med 1992, 20:864-874..
16. Reinhart K, Brunkhorst FM, Bone HG, Bardutzky J, Dempfle CE, Forst H, Gastmeier P, Gerlach H, Grundling M, John S, Kern W, Kreymann G, Kruger W, Kujath P, Marggraf G, Martin J, Mayer K, Meier-Hellmann A, Oppert M, Putensen C, Quintel M, Ragaller M, Rossaint R, Seifert H, Spies C, Stuber F, Weiler N, Weimann A, Werdan K, Welte T. German Interdisciplinary Association for I, Emergency Care M and German Sepsis S [Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI)]. Anaesthesist 2010, 59:347-370. 10.1007/s00101-010-1719-5, 20414762.
17. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829. 10.1097/00003246-198510000-00009, 3928249.
18. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751, 8844239.
19. Kurihara T, Yanagida A, Yokoi H, Koyata A, Matsuya T, Ogawa J, Okamura Y, Miyamoto D. Evaluation of cardiac assays on a benchtop chemiluminescent enzyme immunoassay analyzer, PATHFAST. Anal Biochem 2008, 375:144-146. 10.1016/j.ab.2007.12.030, 18211813.
20. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983, 148:839-843. 10.1148/radiology.148.3.6878708, 6878708.
21. Vodnik T, Kaljevic G, Tadic T, Majkic-Singh N. Presepsin (sCD14-ST) in preoperative diagnosis of abdominal sepsis. Clin Chem Lab Med 2013, 51:2053-2062. 10.1515/cclm-2013-0061, 23740685.
22. Masson S, Caironi P, Spanuth E, Thomae R, Panigada M, Sangiorgi G, Fumagalli R, Mauri T, Isgro S, Fanizza C, Romero M, Tognoni G, Latini R, Gattinoni L. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial. Crit Care 2014, 18:R6. 10.1186/cc13183, 24393424.
23. Bauer M, Press AT, Trauner M. The liver in sepsis: patterns of response and injury. Curr Opin Crit Care 2013, 19:123-127. 10.1097/MCC.0b013e32835eba6d, 23448974.
24. Henriquez-Camacho C, Losa J. Biomarkers for Sepsis. BioMed Res Int 2014, 2014:547818. 10.1155/2014/547818, 24800240.
25. Bloos F, Reinhart K. Rapid diagnosis of sepsis. Virulence 2014, 5:154-160. 10.4161/viru.27393, 24335467.
26. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001, 164:396-402. 10.1164/ajrccm.164.3.2009052, 11500339.
27. Sakr Y, Burgett U, Nacul FE, Reinhart K, Brunkhorst F. Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis?. Crit Care Med 2008, 36:2014-2022. 10.1097/CCM.0b013e31817b86e3, 18552695.
28. Huang DT, Angus DC, Barnato A, Gunn SR, Kellum JA, Stapleton DK, Weissfeld LA, Yealy DM, Peake SL, Delaney A, Bellomo R, Cameron P, Higgins A, Holdgate A, Howe B, Webb SA, Williams P, Osborn TM, Mouncey PR, Harrison DA, Harvey SE, Rowan KM. Harmonizing international trials of early goal-directed resuscitation for severe sepsis and septic shock: methodology of ProCESS, ARISE, and ProMISe. Intensive Care Med 2013, 39:1760-1775. 10.1007/s00134-013-2933-9, 23958738.